Bleakley Financial Group LLC Acquires New Position in TG Therapeutics, Inc. (NASDAQ:TGTX)
Bleakley Financial Group LLC purchased a new stake in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund purchased 8,140 shares of the biopharmaceutical company’s stock, valued at approximately $245,000. A number of other large investors also recently made changes to their positions in TGTX. NBC Securities Inc. […]
![Bleakley Financial Group LLC Acquires New Position in TG Therapeutics, Inc. (NASDAQ:TGTX)](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/tg-therapeutics-inc-logo-1200x675.png?v=20240524063703&w=240&h=240&zc=2)